Hide

FocusBar

Stocks
Gurus

Feedback

Insider Trade Rss Update

Bookmark

insider trade

Market Overview:

Vertex Pharmaceuticals (VRTX) SVP, Corp Affairs & Pub Policy Sachdev Amit's Insider Stock Buys and Sells

Also See:

To find out why GuruFocus thinks data on insider trade are interesting, read

Recent Filings Activity

	Symbol	Company	Insider	Position	Date	Buy/Sell	Shares	Trade Price ($)	Cost ($1000)	Price Change Since Trade (%)	Yield (%)	P/E	Market Cap ($M)	Details
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2012-11-16	Sell	2,287	$41.29	94.4	92.52	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2012-09-21	Sell	9,531	$59	562.3	34.73	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2012-05-07	Sell	58,750	$52.13	3062.6	52.48	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2012-03-30	Sell	26,562	$41.01	1089.3	93.83	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2012-02-08	Sell	4,066	$36.81	149.7	115.95	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2012-01-19	Sell	4,066	$37	150.4	114.84	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2011-07-25	Sell	1,500	$49.92	74.9	59.23	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2011-03-03	Sell	9,531	$49.5	471.8	60.59	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2011-02-28	Sell	15,887	$45.75	726.8	73.75	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2011-02-23	Sell	23,828	$43.8	1043.7	81.48	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2011-01-21	Sell	2,128	$39.92	84.9	99.12	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2011-01-18	Sell	15,664	$39.88	624.7	99.32	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Corp Affairs & Pub Policy	2010-10-28	Sell	4,750	$38.5	182.9	106.47	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Public Policy,Gov Affairs	2010-10-26	Sell	4,534	$37.5	170	111.97	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Public Policy,Gov Affairs	2010-10-18	Sell	1,000	$36.5	36.5	117.78	0.00	132.60	17244.9	Link
	VRTX	Vertex Pharmace...	Sachdev Amit	SVP, Public Policy,Gov Affairs	2010-10-15	Sell	1,000	$35	35	127.11	0.00	132.60	17244.9	Link

Total Records: 16

Add this list into my watchlist/portfolio:

VRTX is Owned by These Gurus:

Guru Name	Portfolio Date*	Current Shares (?)	% of Total Assets (?)	Change from Last Holdings (?)
Vanguard Health Care Fund	2013-03-31	2,489,800	0.54%	+10.97%
Pioneer Investments	2013-03-31	2,422,523	0.53%	-0.66%
Andreas Halvorsen	2013-03-31	780,500	0.26%	New Buy
NWQ Managers	2013-03-31	191,032	0.09%	-23.44%
Jim Simons	2013-03-31	137,417	0.02%	New Buy
Steven Cohen	2013-03-31	13,529	0%	New Buy
Louis Moore Bacon	2013-03-31	0	0%	Sold Out
Most recent portfolio changes are included for Premium Members only!

Related News and Stories:

VRTX: Vertex Pharmaceuticals (VRTX) CEO & President Jeffrey M Leiden sells 33,345 Shares 02-07-2013
VRTX: Vertex Pharmaceuticals (VRTX) EVP & CFO Ian F Smith sells 6,042 Shares 11-20-2012
VRTX: Vertex Pharmaceuticals Inc. Reports Operating Results (10-Q) 11-06-2012
VRTX: Vertex Pharmaceuticals Inc. (VRTX) EVP & CFO Ian F Smith sells 44,787 Shares 10-09-2012
VRTX: Vertex Pharmaceuticals Inc. Reports Operating Results (10-Q) 08-08-2012
VRTX: Vertex Pharmaceuticals Inc. Reports Operating Results (10-Q) 05-10-2012
VRTX: Vertex Pharmaceuticals Inc. Reports Operating Results (10-K) 02-22-2012
VRTX: Vertex Pharmaceuticals Inc. (VRTX) EVP & CFO Ian F Smith sells 9,667 Shares 02-09-2012
VRTX: Vertex Pharmaceuticals Inc. (VRTX) Executive Chairman Matthew Emmens sells 56,000 Shares 02-07-2012
VRTX: Vertex Pharmaceuticals Inc. (VRTX) EVP & CFO Ian F Smith sells 6,042 Shares 01-23-2012
VRTX: Vertex Pharmaceuticals Inc. Reports Operating Results (10-Q) 11-03-2011
VRTX: Vertex Pharmaceuticals Inc. (VRTX) EVP & CFO Ian F Smith sells 12,084 Shares 05-26-2011
VRTX: Vertex Pharmaceuticals Inc. (VRTX) CEO & President Matthew Emmens sells 9,735 Shares 05-26-2011
VRTX: Vertex Pharmaceuticals Inc. (VRTX) EVP & CFO Ian F Smith sells 6,042 Shares 01-26-2011
VRTX: Vertex Pharmaceuticals Inc. (VRTX) EVP & CFO Ian F Smith sells 6,042 Shares 01-25-2011

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Free 7-day Trial

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
© 2004-2013 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.